| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |